GlobeNews Wire

Aerospike Database 8.0 Wins 2025 SiliconANGLE TechForward Awards

MOUNTAIN VIEW, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Aerospike, Inc., today announced that Aerospike Database 8 has been named…

9 months ago

Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases

September 29, 2025 19:30 ET  | Source: Nxera Pharma Tokyo, Japan and Cambridge and London, UK, 30 September 2025 –…

9 months ago

Artelo Biosciences Announces Proposed Underwritten Public Offering

September 29, 2025 19:15 ET  | Source: Artelo Biosciences SOLANA BEACH, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences,…

9 months ago

NANOBIOTIX Announces Updated Phase 1 Results Continuing to Support JNJ-1900 (NBTXR3) Plus Anti-PD-1 as a Potential New 1L or 2L+ Option in Anti-PD-1 Nave or Resistant R/M-HNSCC

Treatment remained well-tolerated with consistent injection feasibility in 103 heavily pre-treated patients with R/M-HNSCC naïve or resistant to anti-PD-163% (26/41)…

9 months ago

45/2025Trifork Group: Reporting of transactions made by persons discharging managerial responsibilities

Schindellegi, Switzerland – 29 September 2025 Trifork Group AGCompany announcement no. 45/2025European Regulatory News Reporting of transactions made by persons…

9 months ago

Exosens secures major contract with the Spanish army for 17 000 advanced night vision monoculars

EXOSENS SECURES MAJOR CONTRACT WITH THE SPANISH ARMY FOR 17 000 ADVANCED NIGHT VISION MONOCULARS PRESS RELEASEMÉRIGNAC, FRANCE – SEPTEMBER, 29th…

9 months ago

Online Crypto Casino No Deposit Bonus 2025 | New Bitcoin Gambling Sites Real Money By Cafe Casino

New York City, NY, Sept. 28, 2025 (GLOBE NEWSWIRE) -- The expansion of digital currency in online entertainment has led…

9 months ago

Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model

Company Announcement Genmab to acquire Merus for USD 97.00 per share in an all-cash transaction representing a transaction value of…

9 months ago

CLINUVEL to advance novel pharmaceutical formulations in preclinical program

Executive summary first biocompatible pharmaceutical formulations progress to preclinical modelsnew sustained-release drug delivery platforms for peptides, melanocortinsaim to predict drug…

9 months ago

LEQEMBI (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimers Disease Approved in China

September 28, 2025 19:30 ET  | Source: Biogen Inc. TOKYO and CAMBRIDGE, Mass., Sept. 28, 2025 (GLOBE NEWSWIRE) -- Eisai…

9 months ago